Promis Neurosciences Inc (PMN.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1 | 1 | 1 | 1 | 1 |
| Accounts receivable | 5 | 12 | -24 | 7 | 4 |
| Accounts payable and accrued liabilities | -93 | N/A | N/A | N/A | N/A |
| Other Working Capital | -278 | -424 | 39 | 289 | -200 |
| Other Operating Activity | -865 | -798 | -1,301 | -1,367 | -776 |
| Operating Cash Flow | $-1,229 | $-1,208 | $-1,284 | $-1,070 | $-970 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 1 | N/A | N/A | N/A |
| Common Stock Issued | N/A | -89 | 3,436 | 44 | 1,955 |
| Common Stock Repurchased | -1 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 1,200 | -1 | -54 | 17 | 0 |
| Financing Cash Flow | $1,199 | $-88 | $3,382 | $61 | $1,955 |
| Beginning Cash Position | 1,308 | 2,648 | 524 | 1,519 | 534 |
| End Cash Position | 1,279 | 1,344 | 2,648 | 524 | 1,519 |
| Net Cash Flow | $-29 | $-1,297 | $2,097 | $-1,008 | $985 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,229 | -1,208 | -1,284 | -1,070 | -970 |
| Free Cash Flow | -1,229 | -1,208 | -1,284 | -1,070 | -970 |